Treatment Side Effects
Conditions
Keywords
myofascial pain syndrome, pain quality
Brief summary
A topical anesthetic gel lidocaine has been widely used as a local anesthetic to reduce the pain and discomfort. It provides local analgesia by blocking the initiation and transmission of impulses. Lidocaine topical anesthetic gel allows the use of high concentrations of the anesthetic bases without concern about local irritation, uneven absorption or systemic toxicity (Argoff, 2000 ). So, the aim of this study is to compare between the effect of lidocaine phonophoresis and pulsed ultrasound in myofascial pain syndrome in swimmers children.
Detailed description
Fourty five children (athletic swimmers) participated in this study, and were classified into three groups ; First control group A : this group consisted of fifteen children were receiving traditional physical therapy program. Second study group B: this group consisted of fifteen children were receiving pulsed ultrasound in addition to traditional physical therapy program as the same as in group A. Third study group C: this group consisted of fifteen children were receiving lidocaine phonophoresis in addition to traditional physical therapy program as the same as in group A. Treatment program in the three groups applied three times a week for three successive months. The study was done in the outpatient clinic of Ismailiy Sporting Club, Ismailia, Egypt.
Interventions
DRUGLidocaine
transmission of the drug molecules to the underlying muscles
DEVICEpulsed ultrasound
using thermogenic and cavitation effect of ultrasound to reduce tight muscles and relieve pain
OTHERespecially designed physical therapy program
by myofascial trigger point release, stretching and strengthening exercises of upper trapezius muscle and infrared radiation by tungsten lamp for upper trapezius
Sponsors
Cairo University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)
Masking description
sealed envelopes
Intervention model description
randomized control trial
Eligibility
Sex/Gender
ALL
Age
10 Years to 14 Years
Healthy volunteers
No
Inclusion criteria
* • Age range from 10 to 14 years. * All children have regional neck pain complaint. * Tenderness in cervical trigger points in the midpoint of the upper border of trapezius muscle, from grade II to grade IV according to tenderness grading scheme (Hubbard and Berkoff, 1993) (Appendix I ) ● The diagnosis of an active MTrP in the upper trapezius according to (Ardiçet al . , 2002 and Bruno, 2005)
Exclusion criteria
* • Neurological disorders. * Dermatological disorders. * Acute trauma prior to the study. * Fibromyalgia, systemic disease and drug allergy history were excluded from the study. * Having myofascial trigger points injection. * Chronic pain in both sides of the body.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| interleukin 6 | three months | measurement of interleukin 6 cncentration in blood plasma |
Countries
Egypt
Outcome results
None listed